Company / Working Capital per Share
Prime Medicine, Inc. Working Capital per Share History
FY2021-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$1.47
FY2024
5-year range
$0.95 / $16.39
FY2021-FY2024
Trend
+54.1%
vs FY2023
Sector context
#166 of 208
Health Care
What the data says
Prime Medicine, Inc.'s working capital per share of $1.47 is lower than 80% of companies in the Health Care sector (FY2024). Working Capital per Share returned to growth in FY2024 after 2 years of decline, reaching $1.47.
Based on SEC 10-K filings.
1.47 in FY2024 with a 3-year CAGR of -55.3%.
Declined from $7.96 to $1.47 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -55.3%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 20% in Health CareTop 80% of 208This company $1.47 Sector average $160.16
▼
-99.1% below sector average
Key checks
Key Insights
- In FY2024, working capital per share increased 54.1% year-over-year.
- Ranks #166 out of 208 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -1.24 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $1.47 | +54.1% |
| FY2023 | $0.95 | -88.1% |
| FY2022 | $7.96 | -51.4% |
| FY2021 | $16.39 | - |
| FY2020 | - | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026